Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress

Marie Stampe Ostenfeld1, Nicole Fehrenbacher, Maria Høyer-Hansen

  • 1Apoptosis Department, Institute for Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.

Cancer Research
|October 6, 2005
PubMed

Insights

Siramesine, a sigma-2 receptor ligand, induces programmed cell death independent of caspases in cancer cells. This novel compound shows promise as an anti-cancer drug for tumors resistant to traditional therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Acquired resistance to caspase-mediated apoptosis is a significant challenge in human cancer treatment.
  • Novel therapeutic strategies are needed to overcome resistance to conventional cancer therapies.

Purpose of the Study:

  • To investigate the potential of siramesine, a sigma-2 receptor ligand, in inducing cancer cell death.
  • To elucidate the mechanism of siramesine-induced cell death and its efficacy in preclinical cancer models.

Main Methods:

  • Siramesine was used to treat immortalized and transformed cells, and its effects on cell death pathways were analyzed.
  • Reactive oxygen species (ROS) levels, lysosomal membrane permeabilization, and morphologic changes were assessed.
  • The role of antioxidants, cathepsin B, Bcl-2, p53, and various protease inhibitors in siramesine-induced cell death was evaluated.
  • The impact of oncogene transformation on siramesine sensitivity was studied.
  • Antitumorigenic effects of siramesine were tested in murine breast cancer and fibrosarcoma models.

Main Results:

  • Siramesine induced caspase-independent programmed cell death, characterized by increased ROS, lysosomal permeabilization, and cellular changes.
  • Lipid-soluble antioxidants (alpha- and gamma-tocopherol) protected cells, while cathepsin B inhibitors offered partial protection.
  • Bcl-2 overexpression, p53 deficiency, and inhibitors of caspases, calpains, or serine proteases did not prevent siramesine-induced death.
  • Oncogenic transformation with c-src or v-Ha-ras sensitized cells to siramesine.
  • Siramesine demonstrated significant antitumorigenic effects in vivo in mouse models.

Conclusions:

  • Siramesine effectively triggers a unique form of programmed cell death that bypasses caspase pathways.
  • The drug's mechanism involves oxidative stress and lysosomal destabilization, with lipid antioxidants showing protective effects.
  • Siramesine exhibits potent antitumor activity in preclinical models, highlighting its potential as a therapeutic agent for drug-resistant cancers.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury IlI: Cellular Death01:11

Cellular Injury IlI: Cellular Death

Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...